Acute Seizure Suppression in Gerbils Did Not Persist Under a Toxic Repeated-THC Regimen
A 1975 gerbil experiment found acute seizure suppression at a high THC dose, followed by loss of protection and severe toxicity during repeated treatment. An initial anticonvulsant observation did not establish a usable treatment window.
The colony and dose conditions were specific
The gerbils came from a colony exhibiting epileptiform seizures. A lower tested dose did not change the reported seizure latency, duration or severity. A higher dose abolished seizures initially. These injected animal conditions cannot be translated directly into clinical cannabis dosing.
Repeated exposure changed benefit and harm differently
By six daily doses, protection at the higher dose was lost. Marked motor depression and other toxic signs increased, and half the animals did not survive. Tolerance to the desired endpoint therefore did not mean tolerance to toxicity or preserved overall safety.
The result does not characterize every cannabinoid
The experiment concerned THC, not purified CBD or every cannabis formulation. It also does not show that an acute reduction in observable seizures necessarily predicts sustained efficacy. Species, seizure model and the harmful regimen limit interpretation.
The study's central lesson is to assess sustained benefit alongside toxicity rather than citing an isolated acute response. It does not support self-treatment or changing prescribed seizure therapy. Its historical preclinical finding illustrates a failed balance between effect persistence and harm under the tested conditions.
Related: interpreting cannabis tolerance claims.
Research cited
Ten Ham M; Loskota WJ; Lomax P. Acute and chronic effects of beta9-tetrahydrocannabinol on seizures in the gerbil. European journal of pharmacology (1975). doi:10.1016/0014-2999(75)90087-4. Findings discussed from the study abstract.
